New Practice Leaders Appointed
RESEARCH TRIANGLE PARK, N.C., April 22 /PRNewswire/ -- Quintiles Transnational Corp. today announced the appointment of three new practice leaders and a business development head as part of its expanding Quintiles Consulting business, which provides pharmaceutical, biotech and medical device companies with strategic guidance to maximize potential and minimize risk from early discovery through commercialization.
Quintiles Consulting is expanding its current services and building a premier global consulting organization to provide strategic, operational and technical advice to pharmaceutical, biotechnology and medical device companies. The organization will focus on market leading issues and address client needs in three practice areas: Product Development and Commercialization, Regulatory and Quality, and Market Access.
The new leadership team members are:
John Doyle, Dr.P.H., M.P.H., Practice Leader, Market Access, U.S. - Doyle leads the U.S. Market Access practice, focusing on market access strategy, health economic assessments, outcomes research, and pricing and reimbursement strategy and support. Doyle will work collaboratively with Dr. Jacco Keja of the Netherlands-based Market Access practice to build the business globally, as well as expand and deepen the group's service offerings.
Doyle joins Quintiles from Analytica International, a health economics
and market access consulting firm he co-founded and led as President. Prior
to that, Doyle directed the Oncology and Immunology Economics Research
Group at Bristol-Myers Squibb. Since 1993, Doyle has authored more than 50
original research articles, in a variety of therapeutic areas, with a
special focus in cardiology, oncology and ophthalmology. He has consulted
with global pharmaceutical and biotech firms on strategic concerns
regarding product development, pricing, reimbursement, market valuation and
|SOURCE Quintiles Transnational Corp.|
Copyright©2008 PR Newswire.
All rights reserved